These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prophylactic myocardial revascularization based on dipyridamole-thallium scanning before peripheral vascular surgery. Steinberg JB; Kresowik TF; Behrendt DM Cardiovasc Surg; 1993 Oct; 1(5):552-7. PubMed ID: 8076096 [TBL] [Abstract][Full Text] [Related]
6. The predictive value of dipyridamole-thallium scintigraphy for cardiac risk assessment before major vascular surgery. Klonaris CN; Bastounis EA; Xiromeritis NC; Balas PE Int Angiol; 1998 Sep; 17(3):171-8. PubMed ID: 9821031 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of dipyridamole thallium-201 screening to minimize perioperative cardiac complications in diabetics undergoing kidney or kidney-pancreas transplantation. Mistry BM; Bastani B; Solomon H; Hoff J; Aridge DL; Lindsey LM; Schmid S; Chaitman BR; Garvin PJ Clin Transplant; 1998 Apr; 12(2):130-5. PubMed ID: 9575401 [TBL] [Abstract][Full Text] [Related]
8. An assessment of the positive predictive value and cost-effectiveness of dipyridamole myocardial scintigraphy in patients undergoing vascular surgery. Bry JD; Belkin M; O'Donnell TF; Mackey WC; Udelson JE; Schmid CH; Safran DG J Vasc Surg; 1994 Jan; 19(1):112-21; discussion 121-4. PubMed ID: 8301724 [TBL] [Abstract][Full Text] [Related]
9. A comparison of dipyridamole-thallium imaging and exercise testing in the prediction of postoperative cardiac complications in patients requiring arterial reconstruction. McPhail NV; Ruddy TD; Calvin JE; Davies RA; Barber GG J Vasc Surg; 1989 Jul; 10(1):51-5; discussion 55-6. PubMed ID: 2746801 [TBL] [Abstract][Full Text] [Related]
10. Prediction of death and myocardial infarction by screening with exercise-thallium testing after coronary-artery-bypass grafting. Lauer MS; Lytle B; Pashkow F; Snader CE; Marwick TH Lancet; 1998 Feb; 351(9103):615-22. PubMed ID: 9500316 [TBL] [Abstract][Full Text] [Related]